Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Melanoma [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/Phase 2 clinical trial evaluating an unspecified vaccine therapy for patients with stage IV melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: Mannkind Corporation | Conditions: Melanoma (Skin) | Phase 1, Phase 2 | Status: COMPLETED